Medical Care
Global Lyme Disease Diagnostic Service Market Research Report 2025
- Mar 13, 25
- ID: 131621
- Pages: 88
- Figures: 88
- Views: 51
The global market for Lyme Disease Diagnostic Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Lyme Disease Diagnostic Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lyme Disease Diagnostic Service.
The Lyme Disease Diagnostic Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lyme Disease Diagnostic Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lyme Disease Diagnostic Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Quidel Corporation
Roche Holding AG
Fujirebio（H.U. Group Holdings）
ZEUS Scientific
IGeneX
Thermo Fisher Scientific
Everlywell
Oxford Immunotec Global PLC(PerkinElmer)
BioMerieux
Bio-Rad Laboratories
T2 Biosystems
Segment by Type
ELISA
Western Blotting
PCR
Others
Segment by Application
Individual
Hospitals and Testing Institutions
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lyme Disease Diagnostic Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Lyme Disease Diagnostic Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lyme Disease Diagnostic Service.
The Lyme Disease Diagnostic Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lyme Disease Diagnostic Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lyme Disease Diagnostic Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Quidel Corporation
Roche Holding AG
Fujirebio（H.U. Group Holdings）
ZEUS Scientific
IGeneX
Thermo Fisher Scientific
Everlywell
Oxford Immunotec Global PLC(PerkinElmer)
BioMerieux
Bio-Rad Laboratories
T2 Biosystems
Segment by Type
ELISA
Western Blotting
PCR
Others
Segment by Application
Individual
Hospitals and Testing Institutions
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lyme Disease Diagnostic Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lyme Disease Diagnostic Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 ELISA
1.2.3 Western Blotting
1.2.4 PCR
1.2.5 Others
1.3 Market by Application
1.3.1 Global Lyme Disease Diagnostic Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Individual
1.3.3 Hospitals and Testing Institutions
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lyme Disease Diagnostic Service Market Perspective (2020-2031)
2.2 Global Lyme Disease Diagnostic Service Growth Trends by Region
2.2.1 Global Lyme Disease Diagnostic Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Lyme Disease Diagnostic Service Historic Market Size by Region (2020-2025)
2.2.3 Lyme Disease Diagnostic Service Forecasted Market Size by Region (2026-2031)
2.3 Lyme Disease Diagnostic Service Market Dynamics
2.3.1 Lyme Disease Diagnostic Service Industry Trends
2.3.2 Lyme Disease Diagnostic Service Market Drivers
2.3.3 Lyme Disease Diagnostic Service Market Challenges
2.3.4 Lyme Disease Diagnostic Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lyme Disease Diagnostic Service Players by Revenue
3.1.1 Global Top Lyme Disease Diagnostic Service Players by Revenue (2020-2025)
3.1.2 Global Lyme Disease Diagnostic Service Revenue Market Share by Players (2020-2025)
3.2 Global Lyme Disease Diagnostic Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Lyme Disease Diagnostic Service Revenue
3.4 Global Lyme Disease Diagnostic Service Market Concentration Ratio
3.4.1 Global Lyme Disease Diagnostic Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lyme Disease Diagnostic Service Revenue in 2024
3.5 Global Key Players of Lyme Disease Diagnostic Service Head office and Area Served
3.6 Global Key Players of Lyme Disease Diagnostic Service, Product and Application
3.7 Global Key Players of Lyme Disease Diagnostic Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Lyme Disease Diagnostic Service Breakdown Data by Type
4.1 Global Lyme Disease Diagnostic Service Historic Market Size by Type (2020-2025)
4.2 Global Lyme Disease Diagnostic Service Forecasted Market Size by Type (2026-2031)
5 Lyme Disease Diagnostic Service Breakdown Data by Application
5.1 Global Lyme Disease Diagnostic Service Historic Market Size by Application (2020-2025)
5.2 Global Lyme Disease Diagnostic Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Lyme Disease Diagnostic Service Market Size (2020-2031)
6.2 North America Lyme Disease Diagnostic Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Lyme Disease Diagnostic Service Market Size by Country (2020-2025)
6.4 North America Lyme Disease Diagnostic Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lyme Disease Diagnostic Service Market Size (2020-2031)
7.2 Europe Lyme Disease Diagnostic Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Lyme Disease Diagnostic Service Market Size by Country (2020-2025)
7.4 Europe Lyme Disease Diagnostic Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lyme Disease Diagnostic Service Market Size (2020-2031)
8.2 Asia-Pacific Lyme Disease Diagnostic Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Lyme Disease Diagnostic Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Lyme Disease Diagnostic Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lyme Disease Diagnostic Service Market Size (2020-2031)
9.2 Latin America Lyme Disease Diagnostic Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Lyme Disease Diagnostic Service Market Size by Country (2020-2025)
9.4 Latin America Lyme Disease Diagnostic Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lyme Disease Diagnostic Service Market Size (2020-2031)
10.2 Middle East & Africa Lyme Disease Diagnostic Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Lyme Disease Diagnostic Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Lyme Disease Diagnostic Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Quidel Corporation
11.1.1 Quidel Corporation Company Details
11.1.2 Quidel Corporation Business Overview
11.1.3 Quidel Corporation Lyme Disease Diagnostic Service Introduction
11.1.4 Quidel Corporation Revenue in Lyme Disease Diagnostic Service Business (2020-2025)
11.1.5 Quidel Corporation Recent Development
11.2 Roche Holding AG
11.2.1 Roche Holding AG Company Details
11.2.2 Roche Holding AG Business Overview
11.2.3 Roche Holding AG Lyme Disease Diagnostic Service Introduction
11.2.4 Roche Holding AG Revenue in Lyme Disease Diagnostic Service Business (2020-2025)
11.2.5 Roche Holding AG Recent Development
11.3 Fujirebio（H.U. Group Holdings）
11.3.1 Fujirebio（H.U. Group Holdings） Company Details
11.3.2 Fujirebio（H.U. Group Holdings） Business Overview
11.3.3 Fujirebio（H.U. Group Holdings） Lyme Disease Diagnostic Service Introduction
11.3.4 Fujirebio（H.U. Group Holdings） Revenue in Lyme Disease Diagnostic Service Business (2020-2025)
11.3.5 Fujirebio（H.U. Group Holdings） Recent Development
11.4 ZEUS Scientific
11.4.1 ZEUS Scientific Company Details
11.4.2 ZEUS Scientific Business Overview
11.4.3 ZEUS Scientific Lyme Disease Diagnostic Service Introduction
11.4.4 ZEUS Scientific Revenue in Lyme Disease Diagnostic Service Business (2020-2025)
11.4.5 ZEUS Scientific Recent Development
11.5 IGeneX
11.5.1 IGeneX Company Details
11.5.2 IGeneX Business Overview
11.5.3 IGeneX Lyme Disease Diagnostic Service Introduction
11.5.4 IGeneX Revenue in Lyme Disease Diagnostic Service Business (2020-2025)
11.5.5 IGeneX Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Lyme Disease Diagnostic Service Introduction
11.6.4 Thermo Fisher Scientific Revenue in Lyme Disease Diagnostic Service Business (2020-2025)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Everlywell
11.7.1 Everlywell Company Details
11.7.2 Everlywell Business Overview
11.7.3 Everlywell Lyme Disease Diagnostic Service Introduction
11.7.4 Everlywell Revenue in Lyme Disease Diagnostic Service Business (2020-2025)
11.7.5 Everlywell Recent Development
11.8 Oxford Immunotec Global PLC(PerkinElmer)
11.8.1 Oxford Immunotec Global PLC(PerkinElmer) Company Details
11.8.2 Oxford Immunotec Global PLC(PerkinElmer) Business Overview
11.8.3 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Diagnostic Service Introduction
11.8.4 Oxford Immunotec Global PLC(PerkinElmer) Revenue in Lyme Disease Diagnostic Service Business (2020-2025)
11.8.5 Oxford Immunotec Global PLC(PerkinElmer) Recent Development
11.9 BioMerieux
11.9.1 BioMerieux Company Details
11.9.2 BioMerieux Business Overview
11.9.3 BioMerieux Lyme Disease Diagnostic Service Introduction
11.9.4 BioMerieux Revenue in Lyme Disease Diagnostic Service Business (2020-2025)
11.9.5 BioMerieux Recent Development
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Details
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories Lyme Disease Diagnostic Service Introduction
11.10.4 Bio-Rad Laboratories Revenue in Lyme Disease Diagnostic Service Business (2020-2025)
11.10.5 Bio-Rad Laboratories Recent Development
11.11 T2 Biosystems
11.11.1 T2 Biosystems Company Details
11.11.2 T2 Biosystems Business Overview
11.11.3 T2 Biosystems Lyme Disease Diagnostic Service Introduction
11.11.4 T2 Biosystems Revenue in Lyme Disease Diagnostic Service Business (2020-2025)
11.11.5 T2 Biosystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lyme Disease Diagnostic Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 ELISA
1.2.3 Western Blotting
1.2.4 PCR
1.2.5 Others
1.3 Market by Application
1.3.1 Global Lyme Disease Diagnostic Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Individual
1.3.3 Hospitals and Testing Institutions
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lyme Disease Diagnostic Service Market Perspective (2020-2031)
2.2 Global Lyme Disease Diagnostic Service Growth Trends by Region
2.2.1 Global Lyme Disease Diagnostic Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Lyme Disease Diagnostic Service Historic Market Size by Region (2020-2025)
2.2.3 Lyme Disease Diagnostic Service Forecasted Market Size by Region (2026-2031)
2.3 Lyme Disease Diagnostic Service Market Dynamics
2.3.1 Lyme Disease Diagnostic Service Industry Trends
2.3.2 Lyme Disease Diagnostic Service Market Drivers
2.3.3 Lyme Disease Diagnostic Service Market Challenges
2.3.4 Lyme Disease Diagnostic Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lyme Disease Diagnostic Service Players by Revenue
3.1.1 Global Top Lyme Disease Diagnostic Service Players by Revenue (2020-2025)
3.1.2 Global Lyme Disease Diagnostic Service Revenue Market Share by Players (2020-2025)
3.2 Global Lyme Disease Diagnostic Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Lyme Disease Diagnostic Service Revenue
3.4 Global Lyme Disease Diagnostic Service Market Concentration Ratio
3.4.1 Global Lyme Disease Diagnostic Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lyme Disease Diagnostic Service Revenue in 2024
3.5 Global Key Players of Lyme Disease Diagnostic Service Head office and Area Served
3.6 Global Key Players of Lyme Disease Diagnostic Service, Product and Application
3.7 Global Key Players of Lyme Disease Diagnostic Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Lyme Disease Diagnostic Service Breakdown Data by Type
4.1 Global Lyme Disease Diagnostic Service Historic Market Size by Type (2020-2025)
4.2 Global Lyme Disease Diagnostic Service Forecasted Market Size by Type (2026-2031)
5 Lyme Disease Diagnostic Service Breakdown Data by Application
5.1 Global Lyme Disease Diagnostic Service Historic Market Size by Application (2020-2025)
5.2 Global Lyme Disease Diagnostic Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Lyme Disease Diagnostic Service Market Size (2020-2031)
6.2 North America Lyme Disease Diagnostic Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Lyme Disease Diagnostic Service Market Size by Country (2020-2025)
6.4 North America Lyme Disease Diagnostic Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lyme Disease Diagnostic Service Market Size (2020-2031)
7.2 Europe Lyme Disease Diagnostic Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Lyme Disease Diagnostic Service Market Size by Country (2020-2025)
7.4 Europe Lyme Disease Diagnostic Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lyme Disease Diagnostic Service Market Size (2020-2031)
8.2 Asia-Pacific Lyme Disease Diagnostic Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Lyme Disease Diagnostic Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Lyme Disease Diagnostic Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lyme Disease Diagnostic Service Market Size (2020-2031)
9.2 Latin America Lyme Disease Diagnostic Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Lyme Disease Diagnostic Service Market Size by Country (2020-2025)
9.4 Latin America Lyme Disease Diagnostic Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lyme Disease Diagnostic Service Market Size (2020-2031)
10.2 Middle East & Africa Lyme Disease Diagnostic Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Lyme Disease Diagnostic Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Lyme Disease Diagnostic Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Quidel Corporation
11.1.1 Quidel Corporation Company Details
11.1.2 Quidel Corporation Business Overview
11.1.3 Quidel Corporation Lyme Disease Diagnostic Service Introduction
11.1.4 Quidel Corporation Revenue in Lyme Disease Diagnostic Service Business (2020-2025)
11.1.5 Quidel Corporation Recent Development
11.2 Roche Holding AG
11.2.1 Roche Holding AG Company Details
11.2.2 Roche Holding AG Business Overview
11.2.3 Roche Holding AG Lyme Disease Diagnostic Service Introduction
11.2.4 Roche Holding AG Revenue in Lyme Disease Diagnostic Service Business (2020-2025)
11.2.5 Roche Holding AG Recent Development
11.3 Fujirebio（H.U. Group Holdings）
11.3.1 Fujirebio（H.U. Group Holdings） Company Details
11.3.2 Fujirebio（H.U. Group Holdings） Business Overview
11.3.3 Fujirebio（H.U. Group Holdings） Lyme Disease Diagnostic Service Introduction
11.3.4 Fujirebio（H.U. Group Holdings） Revenue in Lyme Disease Diagnostic Service Business (2020-2025)
11.3.5 Fujirebio（H.U. Group Holdings） Recent Development
11.4 ZEUS Scientific
11.4.1 ZEUS Scientific Company Details
11.4.2 ZEUS Scientific Business Overview
11.4.3 ZEUS Scientific Lyme Disease Diagnostic Service Introduction
11.4.4 ZEUS Scientific Revenue in Lyme Disease Diagnostic Service Business (2020-2025)
11.4.5 ZEUS Scientific Recent Development
11.5 IGeneX
11.5.1 IGeneX Company Details
11.5.2 IGeneX Business Overview
11.5.3 IGeneX Lyme Disease Diagnostic Service Introduction
11.5.4 IGeneX Revenue in Lyme Disease Diagnostic Service Business (2020-2025)
11.5.5 IGeneX Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Lyme Disease Diagnostic Service Introduction
11.6.4 Thermo Fisher Scientific Revenue in Lyme Disease Diagnostic Service Business (2020-2025)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Everlywell
11.7.1 Everlywell Company Details
11.7.2 Everlywell Business Overview
11.7.3 Everlywell Lyme Disease Diagnostic Service Introduction
11.7.4 Everlywell Revenue in Lyme Disease Diagnostic Service Business (2020-2025)
11.7.5 Everlywell Recent Development
11.8 Oxford Immunotec Global PLC(PerkinElmer)
11.8.1 Oxford Immunotec Global PLC(PerkinElmer) Company Details
11.8.2 Oxford Immunotec Global PLC(PerkinElmer) Business Overview
11.8.3 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Diagnostic Service Introduction
11.8.4 Oxford Immunotec Global PLC(PerkinElmer) Revenue in Lyme Disease Diagnostic Service Business (2020-2025)
11.8.5 Oxford Immunotec Global PLC(PerkinElmer) Recent Development
11.9 BioMerieux
11.9.1 BioMerieux Company Details
11.9.2 BioMerieux Business Overview
11.9.3 BioMerieux Lyme Disease Diagnostic Service Introduction
11.9.4 BioMerieux Revenue in Lyme Disease Diagnostic Service Business (2020-2025)
11.9.5 BioMerieux Recent Development
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Details
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories Lyme Disease Diagnostic Service Introduction
11.10.4 Bio-Rad Laboratories Revenue in Lyme Disease Diagnostic Service Business (2020-2025)
11.10.5 Bio-Rad Laboratories Recent Development
11.11 T2 Biosystems
11.11.1 T2 Biosystems Company Details
11.11.2 T2 Biosystems Business Overview
11.11.3 T2 Biosystems Lyme Disease Diagnostic Service Introduction
11.11.4 T2 Biosystems Revenue in Lyme Disease Diagnostic Service Business (2020-2025)
11.11.5 T2 Biosystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Lyme Disease Diagnostic Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of ELISA
Table 3. Key Players of Western Blotting
Table 4. Key Players of PCR
Table 5. Key Players of Others
Table 6. Global Lyme Disease Diagnostic Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Lyme Disease Diagnostic Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Lyme Disease Diagnostic Service Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Lyme Disease Diagnostic Service Market Share by Region (2020-2025)
Table 10. Global Lyme Disease Diagnostic Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Lyme Disease Diagnostic Service Market Share by Region (2026-2031)
Table 12. Lyme Disease Diagnostic Service Market Trends
Table 13. Lyme Disease Diagnostic Service Market Drivers
Table 14. Lyme Disease Diagnostic Service Market Challenges
Table 15. Lyme Disease Diagnostic Service Market Restraints
Table 16. Global Lyme Disease Diagnostic Service Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Lyme Disease Diagnostic Service Market Share by Players (2020-2025)
Table 18. Global Top Lyme Disease Diagnostic Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lyme Disease Diagnostic Service as of 2024)
Table 19. Ranking of Global Top Lyme Disease Diagnostic Service Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Lyme Disease Diagnostic Service Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Lyme Disease Diagnostic Service, Headquarters and Area Served
Table 22. Global Key Players of Lyme Disease Diagnostic Service, Product and Application
Table 23. Global Key Players of Lyme Disease Diagnostic Service, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Lyme Disease Diagnostic Service Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Lyme Disease Diagnostic Service Revenue Market Share by Type (2020-2025)
Table 27. Global Lyme Disease Diagnostic Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Lyme Disease Diagnostic Service Revenue Market Share by Type (2026-2031)
Table 29. Global Lyme Disease Diagnostic Service Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Lyme Disease Diagnostic Service Revenue Market Share by Application (2020-2025)
Table 31. Global Lyme Disease Diagnostic Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Lyme Disease Diagnostic Service Revenue Market Share by Application (2026-2031)
Table 33. North America Lyme Disease Diagnostic Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Lyme Disease Diagnostic Service Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Lyme Disease Diagnostic Service Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Lyme Disease Diagnostic Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Lyme Disease Diagnostic Service Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Lyme Disease Diagnostic Service Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Lyme Disease Diagnostic Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Lyme Disease Diagnostic Service Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Lyme Disease Diagnostic Service Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Lyme Disease Diagnostic Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Lyme Disease Diagnostic Service Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Lyme Disease Diagnostic Service Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Lyme Disease Diagnostic Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Lyme Disease Diagnostic Service Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Lyme Disease Diagnostic Service Market Size by Country (2026-2031) & (US$ Million)
Table 48. Quidel Corporation Company Details
Table 49. Quidel Corporation Business Overview
Table 50. Quidel Corporation Lyme Disease Diagnostic Service Product
Table 51. Quidel Corporation Revenue in Lyme Disease Diagnostic Service Business (2020-2025) & (US$ Million)
Table 52. Quidel Corporation Recent Development
Table 53. Roche Holding AG Company Details
Table 54. Roche Holding AG Business Overview
Table 55. Roche Holding AG Lyme Disease Diagnostic Service Product
Table 56. Roche Holding AG Revenue in Lyme Disease Diagnostic Service Business (2020-2025) & (US$ Million)
Table 57. Roche Holding AG Recent Development
Table 58. Fujirebio（H.U. Group Holdings） Company Details
Table 59. Fujirebio（H.U. Group Holdings） Business Overview
Table 60. Fujirebio（H.U. Group Holdings） Lyme Disease Diagnostic Service Product
Table 61. Fujirebio（H.U. Group Holdings） Revenue in Lyme Disease Diagnostic Service Business (2020-2025) & (US$ Million)
Table 62. Fujirebio（H.U. Group Holdings） Recent Development
Table 63. ZEUS Scientific Company Details
Table 64. ZEUS Scientific Business Overview
Table 65. ZEUS Scientific Lyme Disease Diagnostic Service Product
Table 66. ZEUS Scientific Revenue in Lyme Disease Diagnostic Service Business (2020-2025) & (US$ Million)
Table 67. ZEUS Scientific Recent Development
Table 68. IGeneX Company Details
Table 69. IGeneX Business Overview
Table 70. IGeneX Lyme Disease Diagnostic Service Product
Table 71. IGeneX Revenue in Lyme Disease Diagnostic Service Business (2020-2025) & (US$ Million)
Table 72. IGeneX Recent Development
Table 73. Thermo Fisher Scientific Company Details
Table 74. Thermo Fisher Scientific Business Overview
Table 75. Thermo Fisher Scientific Lyme Disease Diagnostic Service Product
Table 76. Thermo Fisher Scientific Revenue in Lyme Disease Diagnostic Service Business (2020-2025) & (US$ Million)
Table 77. Thermo Fisher Scientific Recent Development
Table 78. Everlywell Company Details
Table 79. Everlywell Business Overview
Table 80. Everlywell Lyme Disease Diagnostic Service Product
Table 81. Everlywell Revenue in Lyme Disease Diagnostic Service Business (2020-2025) & (US$ Million)
Table 82. Everlywell Recent Development
Table 83. Oxford Immunotec Global PLC(PerkinElmer) Company Details
Table 84. Oxford Immunotec Global PLC(PerkinElmer) Business Overview
Table 85. Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Diagnostic Service Product
Table 86. Oxford Immunotec Global PLC(PerkinElmer) Revenue in Lyme Disease Diagnostic Service Business (2020-2025) & (US$ Million)
Table 87. Oxford Immunotec Global PLC(PerkinElmer) Recent Development
Table 88. BioMerieux Company Details
Table 89. BioMerieux Business Overview
Table 90. BioMerieux Lyme Disease Diagnostic Service Product
Table 91. BioMerieux Revenue in Lyme Disease Diagnostic Service Business (2020-2025) & (US$ Million)
Table 92. BioMerieux Recent Development
Table 93. Bio-Rad Laboratories Company Details
Table 94. Bio-Rad Laboratories Business Overview
Table 95. Bio-Rad Laboratories Lyme Disease Diagnostic Service Product
Table 96. Bio-Rad Laboratories Revenue in Lyme Disease Diagnostic Service Business (2020-2025) & (US$ Million)
Table 97. Bio-Rad Laboratories Recent Development
Table 98. T2 Biosystems Company Details
Table 99. T2 Biosystems Business Overview
Table 100. T2 Biosystems Lyme Disease Diagnostic Service Product
Table 101. T2 Biosystems Revenue in Lyme Disease Diagnostic Service Business (2020-2025) & (US$ Million)
Table 102. T2 Biosystems Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Lyme Disease Diagnostic Service Picture
Figure 2. Global Lyme Disease Diagnostic Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Lyme Disease Diagnostic Service Market Share by Type: 2024 VS 2031
Figure 4. ELISA Features
Figure 5. Western Blotting Features
Figure 6. PCR Features
Figure 7. Others Features
Figure 8. Global Lyme Disease Diagnostic Service Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Lyme Disease Diagnostic Service Market Share by Application: 2024 VS 2031
Figure 10. Individual Case Studies
Figure 11. Hospitals and Testing Institutions Case Studies
Figure 12. Others Case Studies
Figure 13. Lyme Disease Diagnostic Service Report Years Considered
Figure 14. Global Lyme Disease Diagnostic Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Lyme Disease Diagnostic Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Lyme Disease Diagnostic Service Market Share by Region: 2024 VS 2031
Figure 17. Global Lyme Disease Diagnostic Service Market Share by Players in 2024
Figure 18. Global Top Lyme Disease Diagnostic Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lyme Disease Diagnostic Service as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Lyme Disease Diagnostic Service Revenue in 2024
Figure 20. North America Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Lyme Disease Diagnostic Service Market Share by Country (2020-2031)
Figure 22. United States Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Lyme Disease Diagnostic Service Market Share by Country (2020-2031)
Figure 26. Germany Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Lyme Disease Diagnostic Service Market Share by Region (2020-2031)
Figure 34. China Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Lyme Disease Diagnostic Service Market Share by Country (2020-2031)
Figure 42. Mexico Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Lyme Disease Diagnostic Service Market Share by Country (2020-2031)
Figure 46. Turkey Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Quidel Corporation Revenue Growth Rate in Lyme Disease Diagnostic Service Business (2020-2025)
Figure 50. Roche Holding AG Revenue Growth Rate in Lyme Disease Diagnostic Service Business (2020-2025)
Figure 51. Fujirebio（H.U. Group Holdings） Revenue Growth Rate in Lyme Disease Diagnostic Service Business (2020-2025)
Figure 52. ZEUS Scientific Revenue Growth Rate in Lyme Disease Diagnostic Service Business (2020-2025)
Figure 53. IGeneX Revenue Growth Rate in Lyme Disease Diagnostic Service Business (2020-2025)
Figure 54. Thermo Fisher Scientific Revenue Growth Rate in Lyme Disease Diagnostic Service Business (2020-2025)
Figure 55. Everlywell Revenue Growth Rate in Lyme Disease Diagnostic Service Business (2020-2025)
Figure 56. Oxford Immunotec Global PLC(PerkinElmer) Revenue Growth Rate in Lyme Disease Diagnostic Service Business (2020-2025)
Figure 57. BioMerieux Revenue Growth Rate in Lyme Disease Diagnostic Service Business (2020-2025)
Figure 58. Bio-Rad Laboratories Revenue Growth Rate in Lyme Disease Diagnostic Service Business (2020-2025)
Figure 59. T2 Biosystems Revenue Growth Rate in Lyme Disease Diagnostic Service Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Lyme Disease Diagnostic Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of ELISA
Table 3. Key Players of Western Blotting
Table 4. Key Players of PCR
Table 5. Key Players of Others
Table 6. Global Lyme Disease Diagnostic Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Lyme Disease Diagnostic Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Lyme Disease Diagnostic Service Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Lyme Disease Diagnostic Service Market Share by Region (2020-2025)
Table 10. Global Lyme Disease Diagnostic Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Lyme Disease Diagnostic Service Market Share by Region (2026-2031)
Table 12. Lyme Disease Diagnostic Service Market Trends
Table 13. Lyme Disease Diagnostic Service Market Drivers
Table 14. Lyme Disease Diagnostic Service Market Challenges
Table 15. Lyme Disease Diagnostic Service Market Restraints
Table 16. Global Lyme Disease Diagnostic Service Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Lyme Disease Diagnostic Service Market Share by Players (2020-2025)
Table 18. Global Top Lyme Disease Diagnostic Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lyme Disease Diagnostic Service as of 2024)
Table 19. Ranking of Global Top Lyme Disease Diagnostic Service Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Lyme Disease Diagnostic Service Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Lyme Disease Diagnostic Service, Headquarters and Area Served
Table 22. Global Key Players of Lyme Disease Diagnostic Service, Product and Application
Table 23. Global Key Players of Lyme Disease Diagnostic Service, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Lyme Disease Diagnostic Service Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Lyme Disease Diagnostic Service Revenue Market Share by Type (2020-2025)
Table 27. Global Lyme Disease Diagnostic Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Lyme Disease Diagnostic Service Revenue Market Share by Type (2026-2031)
Table 29. Global Lyme Disease Diagnostic Service Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Lyme Disease Diagnostic Service Revenue Market Share by Application (2020-2025)
Table 31. Global Lyme Disease Diagnostic Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Lyme Disease Diagnostic Service Revenue Market Share by Application (2026-2031)
Table 33. North America Lyme Disease Diagnostic Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Lyme Disease Diagnostic Service Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Lyme Disease Diagnostic Service Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Lyme Disease Diagnostic Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Lyme Disease Diagnostic Service Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Lyme Disease Diagnostic Service Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Lyme Disease Diagnostic Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Lyme Disease Diagnostic Service Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Lyme Disease Diagnostic Service Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Lyme Disease Diagnostic Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Lyme Disease Diagnostic Service Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Lyme Disease Diagnostic Service Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Lyme Disease Diagnostic Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Lyme Disease Diagnostic Service Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Lyme Disease Diagnostic Service Market Size by Country (2026-2031) & (US$ Million)
Table 48. Quidel Corporation Company Details
Table 49. Quidel Corporation Business Overview
Table 50. Quidel Corporation Lyme Disease Diagnostic Service Product
Table 51. Quidel Corporation Revenue in Lyme Disease Diagnostic Service Business (2020-2025) & (US$ Million)
Table 52. Quidel Corporation Recent Development
Table 53. Roche Holding AG Company Details
Table 54. Roche Holding AG Business Overview
Table 55. Roche Holding AG Lyme Disease Diagnostic Service Product
Table 56. Roche Holding AG Revenue in Lyme Disease Diagnostic Service Business (2020-2025) & (US$ Million)
Table 57. Roche Holding AG Recent Development
Table 58. Fujirebio（H.U. Group Holdings） Company Details
Table 59. Fujirebio（H.U. Group Holdings） Business Overview
Table 60. Fujirebio（H.U. Group Holdings） Lyme Disease Diagnostic Service Product
Table 61. Fujirebio（H.U. Group Holdings） Revenue in Lyme Disease Diagnostic Service Business (2020-2025) & (US$ Million)
Table 62. Fujirebio（H.U. Group Holdings） Recent Development
Table 63. ZEUS Scientific Company Details
Table 64. ZEUS Scientific Business Overview
Table 65. ZEUS Scientific Lyme Disease Diagnostic Service Product
Table 66. ZEUS Scientific Revenue in Lyme Disease Diagnostic Service Business (2020-2025) & (US$ Million)
Table 67. ZEUS Scientific Recent Development
Table 68. IGeneX Company Details
Table 69. IGeneX Business Overview
Table 70. IGeneX Lyme Disease Diagnostic Service Product
Table 71. IGeneX Revenue in Lyme Disease Diagnostic Service Business (2020-2025) & (US$ Million)
Table 72. IGeneX Recent Development
Table 73. Thermo Fisher Scientific Company Details
Table 74. Thermo Fisher Scientific Business Overview
Table 75. Thermo Fisher Scientific Lyme Disease Diagnostic Service Product
Table 76. Thermo Fisher Scientific Revenue in Lyme Disease Diagnostic Service Business (2020-2025) & (US$ Million)
Table 77. Thermo Fisher Scientific Recent Development
Table 78. Everlywell Company Details
Table 79. Everlywell Business Overview
Table 80. Everlywell Lyme Disease Diagnostic Service Product
Table 81. Everlywell Revenue in Lyme Disease Diagnostic Service Business (2020-2025) & (US$ Million)
Table 82. Everlywell Recent Development
Table 83. Oxford Immunotec Global PLC(PerkinElmer) Company Details
Table 84. Oxford Immunotec Global PLC(PerkinElmer) Business Overview
Table 85. Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Diagnostic Service Product
Table 86. Oxford Immunotec Global PLC(PerkinElmer) Revenue in Lyme Disease Diagnostic Service Business (2020-2025) & (US$ Million)
Table 87. Oxford Immunotec Global PLC(PerkinElmer) Recent Development
Table 88. BioMerieux Company Details
Table 89. BioMerieux Business Overview
Table 90. BioMerieux Lyme Disease Diagnostic Service Product
Table 91. BioMerieux Revenue in Lyme Disease Diagnostic Service Business (2020-2025) & (US$ Million)
Table 92. BioMerieux Recent Development
Table 93. Bio-Rad Laboratories Company Details
Table 94. Bio-Rad Laboratories Business Overview
Table 95. Bio-Rad Laboratories Lyme Disease Diagnostic Service Product
Table 96. Bio-Rad Laboratories Revenue in Lyme Disease Diagnostic Service Business (2020-2025) & (US$ Million)
Table 97. Bio-Rad Laboratories Recent Development
Table 98. T2 Biosystems Company Details
Table 99. T2 Biosystems Business Overview
Table 100. T2 Biosystems Lyme Disease Diagnostic Service Product
Table 101. T2 Biosystems Revenue in Lyme Disease Diagnostic Service Business (2020-2025) & (US$ Million)
Table 102. T2 Biosystems Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Lyme Disease Diagnostic Service Picture
Figure 2. Global Lyme Disease Diagnostic Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Lyme Disease Diagnostic Service Market Share by Type: 2024 VS 2031
Figure 4. ELISA Features
Figure 5. Western Blotting Features
Figure 6. PCR Features
Figure 7. Others Features
Figure 8. Global Lyme Disease Diagnostic Service Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Lyme Disease Diagnostic Service Market Share by Application: 2024 VS 2031
Figure 10. Individual Case Studies
Figure 11. Hospitals and Testing Institutions Case Studies
Figure 12. Others Case Studies
Figure 13. Lyme Disease Diagnostic Service Report Years Considered
Figure 14. Global Lyme Disease Diagnostic Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Lyme Disease Diagnostic Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Lyme Disease Diagnostic Service Market Share by Region: 2024 VS 2031
Figure 17. Global Lyme Disease Diagnostic Service Market Share by Players in 2024
Figure 18. Global Top Lyme Disease Diagnostic Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lyme Disease Diagnostic Service as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Lyme Disease Diagnostic Service Revenue in 2024
Figure 20. North America Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Lyme Disease Diagnostic Service Market Share by Country (2020-2031)
Figure 22. United States Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Lyme Disease Diagnostic Service Market Share by Country (2020-2031)
Figure 26. Germany Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Lyme Disease Diagnostic Service Market Share by Region (2020-2031)
Figure 34. China Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Lyme Disease Diagnostic Service Market Share by Country (2020-2031)
Figure 42. Mexico Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Lyme Disease Diagnostic Service Market Share by Country (2020-2031)
Figure 46. Turkey Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Lyme Disease Diagnostic Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Quidel Corporation Revenue Growth Rate in Lyme Disease Diagnostic Service Business (2020-2025)
Figure 50. Roche Holding AG Revenue Growth Rate in Lyme Disease Diagnostic Service Business (2020-2025)
Figure 51. Fujirebio（H.U. Group Holdings） Revenue Growth Rate in Lyme Disease Diagnostic Service Business (2020-2025)
Figure 52. ZEUS Scientific Revenue Growth Rate in Lyme Disease Diagnostic Service Business (2020-2025)
Figure 53. IGeneX Revenue Growth Rate in Lyme Disease Diagnostic Service Business (2020-2025)
Figure 54. Thermo Fisher Scientific Revenue Growth Rate in Lyme Disease Diagnostic Service Business (2020-2025)
Figure 55. Everlywell Revenue Growth Rate in Lyme Disease Diagnostic Service Business (2020-2025)
Figure 56. Oxford Immunotec Global PLC(PerkinElmer) Revenue Growth Rate in Lyme Disease Diagnostic Service Business (2020-2025)
Figure 57. BioMerieux Revenue Growth Rate in Lyme Disease Diagnostic Service Business (2020-2025)
Figure 58. Bio-Rad Laboratories Revenue Growth Rate in Lyme Disease Diagnostic Service Business (2020-2025)
Figure 59. T2 Biosystems Revenue Growth Rate in Lyme Disease Diagnostic Service Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232